GERN Q1 2023 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$21,000-82.9% YoY

Gross Profit

$21,000100.0% margin

Operating Income

-$40M-190914.3% margin

Net Income

-$38M-181533.3% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

-79.6%

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$47M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$425M

Total Liabilities

$99M

Stockholders' Equity

$326M

Cash & Equivalents

$113M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21,000	$123,000	-82.9%
Gross Profit	$21,000	-$22M	+100.1%
Operating Income	-$40M	-$29M	-39.8%
Net Income	-$38M	-$30M	-26.7%